New marker could numb skin in minutes, study says

NCT ID NCT07273916

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Phase 2 trial tests a topical anesthetic marker applied to the skin to reduce pain from needle pricks. Twenty adults will have the marker applied to their forearm, and pain will be measured every 10 minutes for 40 minutes compared to untreated skin. The goal is to see how well and how fast it works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
topical anesthetic marker (lidocaine, tetracaine, Transcutol P, and dye)
What this could lead to
If it works, this could provide a quick, easy-to-use topical anesthetic for minor procedures like injections or blood draws.
What could go wrong
This is a small, early-phase trial with only 20 people, testing pain from light pricks on the forearm—not real medical procedures. The effect may not translate to clinical settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.